SAMPLING BIAS IN ESTIMATING DESIGN-II VARIANCE-COMPONENTS WITH S-1 FAMILIES

被引：0
|
作者：
JONES, LP [1 ]
COMPTON, WA [1 ]
机构：
[1] UNIV NEBRASKA,AGRON,LINCOLN,NE 68588
来源：
THEORETICAL AND APPLIED GENETICS | 1985年 / 70卷 / 03期
关键词：
D O I：
10.1007/BF00304919
中图分类号：
S3 [农学（农艺学）];
学科分类号：
0901 ;
摘要：
引用
收藏
页码：318 / 321
页数：4
相关论文
共 9 条
  • [1] SAMPLING DESIGNS FOR ESTIMATING SPATIAL VARIANCE-COMPONENTS
    PETTITT, AN
    MCBRATNEY, AB
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 1993, 42 (01) : 185 - 209
  • [2] BIAS AND SAMPLING COVARIANCES OF ESTIMATES OF VARIANCE-COMPONENTS DUE TO MATERNAL EFFECTS
    MEYER, K
    GENETICS SELECTION EVOLUTION, 1992, 24 (06) : 487 - 509
  • [3] ROBUSTNESS OF THE VARIANCE OF THE ESTIMATED VARIANCE-COMPONENTS IN A MODEL-II OF A SIMPLE EXPERIMENTAL-DESIGN - DESIGNING OF EXPERIMENTS
    HERRENDORFER, G
    GUIARD, V
    ARCHIV FUR TIERZUCHT-ARCHIVES OF ANIMAL BREEDING, 1993, 36 (05): : 571 - 579
  • [4] ROBUST INFERENCE FOR VARIANCE-COMPONENTS MODELS IN FAMILIES ASCERTAINED THROUGH PROBANDS .1. CONDITIONING ON PROBANDS PHENOTYPE
    BEATY, TH
    LIANG, KY
    GENETIC EPIDEMIOLOGY, 1987, 4 (03) : 203 - 210
  • [5] A randomized phase II factorial design trial of CPT-11 versus PTX versus each combination with S-1 in patients with advanced gastric cancer refractory to S-1: Final results of OGSG0701.
    Nishikawa, Kazuhiro
    Imamura, Hiroshi
    Kawase, Tomono
    Gotoh, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Kawada, Junji
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Sakai, Daisuke
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [6] Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial
    Zhu, Xiaofei
    Ju, Xiaoping
    Cao, Fei
    Fang, Fang
    Qing, Shuiwang
    Shen, Yuxin
    Jia, Zhen
    Cao, Yangsen
    Zhang, Huojun
    BMJ OPEN, 2016, 6 (12):
  • [7] A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study
    Tsuchiya, Tomoshi
    Matsumoto, Keitaro
    Miyazaki, Takuro
    Doi, Ryoichiro
    Tokunaga, Shoji
    Yamaguchi, Hiroyuki
    Tomoshige, Koichi
    Watanabe, Hironosuke
    Nagayasu, Takeshi
    Sugio, Kenji
    BMC CANCER, 2021, 21 (01)
  • [8] A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study
    Tomoshi Tsuchiya
    Keitaro Matsumoto
    Takuro Miyazaki
    Ryoichiro Doi
    Shoji Tokunaga
    Hiroyuki Yamaguchi
    Koichi Tomoshige
    Hironosuke Watanabe
    Takeshi Nagayasu
    Kenji Sugio
    BMC Cancer, 21
  • [9] Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy
    Morita, S
    Ohashi, Y
    Hirakawa, K
    Nakata, B
    Saji, S
    Sakamoto, J
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (03) : 159 - 161
1